Zurück zu Projekte

25598.2 PFNM-NM

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Zusammenfassung

Illuneo: a non-invasive, continuous blood glucose bedside measurement for preterm infants at the neonatal intensive care unit

Weitere Texte

Abstract

The aim is to prevent impaired brain development in extreme and very preterm neonates in addition to reducing pain, infection risks, and to lowering costs for hospitals via continuous, non-invasive, transdermal, auto-calibrating glucose monitoring with passive diffusion. We developed, patented and tested in vitro a novel measurement principle with two parallel measurements for calibrating skin resistance. We now need to prove our new principle in a clinical pilot trial.

Beteiligte

Martin Wolf

Kontaktperson

martin.wolf@usz.ch

USZ Universitätsspital Zürich Martin Wolf Frauenklinikstrasse 10 8091 Zürich ZH CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-03-31
Enddatum
2018-12-31
Bewilligte Gesamtkosten
CHF 150000.00
Sektion
22 Förderbereich Nano / Micro
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T171 Microelectronics 100.0%